Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3516 results

Sort By:

Evaluating Metabolic Health in People Aged 18 to 60 by Neutralite Metabolic Health Index

Study ID: NCT07161557
Start Date: 2025-10-09
End Date: 2026-05-10
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

No Intervention: Observational Cohort

Sponsor

Amway (China) R&D Center

Source: clinicaltrials.gov

Share:
Add to list

Efficacy of NOSHINtrial in Diabetic Patients

Study ID: NCT06205030
Start Date: 2025-09-26
End Date: 2027-08-16
Study Type

Interventional

Study Phase

Phase4

No. of Participants

70

Intervention / Treatment

anti-diabetic herbal drug

Sponsor

Kerman Medical University

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Study ID: NCT06651177
Start Date: 2025-11-19
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

310

Intervention / Treatment

Tirzepatide

Placebo

Sponsor

T. John Winhusen, PhD

Source: clinicaltrials.gov

Share:
Add to list

A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial

Study ID: NCT07119489
Start Date: 2025-10
End Date: 2026-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

16

Intervention / Treatment

Dialectical Behavior Therapy -Skill Training brief intervention

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood

Study ID: NCT06241560
Start Date: 2025-10-20
End Date: 2026-02-20
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

BI 1015550

Pirfenidone

Sponsor

Boehringer Ingelheim

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

Study ID: NCT06887348
Start Date: 2025-11-01
End Date: 2035-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Observational study with no interventions

Sponsor

Replimune Inc.

Source: clinicaltrials.gov

Share:
Add to list

The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States

Study ID: NCT07027826
Start Date: 2025-09-14
End Date: 2027-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

70

Intervention / Treatment

Esophageal string test

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Source: clinicaltrials.gov

Share:
Add to list

Prognostic IntraOperative Biomarkers ideNtification in Tumor rElatEd suRgery

Study ID: NCT06617208
Start Date: 2025-12-01
End Date: 2029-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Neuropixel probe recording

Sponsor

Erasmus Medical Center

Source: clinicaltrials.gov

Share:
Add to list

SAMe in Prevention of Oxaliplatin-associated Liver Injury

Study ID: NCT06258525
Start Date: 2025-09-15
End Date: 2028-02-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Standard of care oxaliplatin-based chemotherapy

S-adenosylmethionine (SAMe) supplement

Surgery

Sponsor

Cedars-Sinai Medical Center

Source: clinicaltrials.gov

Share:
Add to list

A Post-market Registry to Assess Safety and Performance of RefluxStop™ in the Treatment of GERD in General Hospital Practice

Study ID: NCT07004439
Start Date: 2025-09-15
End Date: 2035-08-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment

RefluxStop™ implantation

Sponsor

Implantica CE Reflux Ltd.

Source: clinicaltrials.gov

Share:
Add to list